Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “APREA AB”

6 pharma patents match "APREA AB" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "APREA AB" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “APREA AB” · 30,257 patents in full index Clear search

  1. US 9061016

    Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease

    APREA AB · Granted Jun 23, 2015 · Expires Jun 18, 2035

    granted

  2. US 7902167

    Compounds and methods for down-regulating Wrap53 protein by RNA interference

    APREA AB · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  3. US 7759361

    Azabicyclooctan-3-one derivatives and use thereof

    APREA AB · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  4. US 7659278

    Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases

    APREA AB · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  5. US 7348330

    1-azabicyclo [2,2,2] octan-3-one derivatives

    APREA AB · Granted Mar 25, 2008 · Expires Mar 20, 2028

    granted

  6. US 6921765

    1-Azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors

    APREA AB · Granted Jul 26, 2005 · Expires Jul 21, 2025

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.